Evaluation of Antiemetic Drugs Use in Chemotherapy Breast Cancer Patients at Dr. Pirngadi Medan Hospital
- DOI
- 10.2991/ahsr.k.211105.004How to use a DOI?
- Keywords
- Antiemetic; Breast Cancer; Chemotrapy; Proliferation; Nausea
- Abstract
Breast cancer is excessive cell proliferation that attacks the breast tissue. Breast cancer is a problem that requires serious attention, especially for women. Breast cancer is currently the first cause of death in women in the world. Nausea and vomiting caused by chemotherapy is one of the side effects that most often affects the quality of life of cancer patients undergoing chemotherapy. These side effects can be prevented by administering antiemetic drug therapy. Accuracy in the administration of antiemetic drugs will increase the safety and effectiveness of drug use. This study aims to evaluation of antiemetic treatment therapy based on the accuracy of drug selection, dosage and the resulting therapeutic effect. This study used a purposive sampling method by collecting data retrospectively, namely monitoring the use of antiemetics in breast cancer chemotherapy patients in the inpatient room of RSUD Dr. Pirngadi Medan. The results of this study obtained 20 patients who entered the inclusion criteria, seen as many as 100% of patients received antiemetics with appropriate doses, and as many as 100% of patients received the appropriate drugs.
- Copyright
- © 2021 The Authors. Published by Atlantis Press International B.V.
- Open Access
- This is an open access article under the CC BY-NC license.
Cite this article
TY - CONF AU - Eva Sartika Dasopang AU - Fenny Hasanah AU - Desy Natalia Siahaan AU - Jamilah Nasution PY - 2021 DA - 2021/11/17 TI - Evaluation of Antiemetic Drugs Use in Chemotherapy Breast Cancer Patients at Dr. Pirngadi Medan Hospital BT - Proceedings of the 2nd International Conference on Contemporary Science and Clinical Pharmacy 2021 (ICCSCP 2021) PB - Atlantis Press SP - 21 EP - 29 SN - 2468-5739 UR - https://doi.org/10.2991/ahsr.k.211105.004 DO - 10.2991/ahsr.k.211105.004 ID - Dasopang2021 ER -